Thomas Christine E 4
4 · FEMASYS INC · Filed Nov 1, 2023
Insider Transaction Report
Form 4
FEMASYS INCFEMY
Thomas Christine E
SVP, Regulatory & Clinical
Transactions
- Award
Stock Option (Right to Buy)
[F1]2023-10-10+60,000→ 60,000 totalExercise: $1.76Exp: 2033-10-10→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact|2023-11-01